Nomura Holdings’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.15M Buy
5,246
+212
+4% +$46.4K ﹤0.01% 425
2025
Q1
$1.13M Buy
5,034
+2,652
+111% +$594K ﹤0.01% 624
2024
Q4
$780K Sell
2,382
-1,556
-40% -$510K ﹤0.01% 980
2024
Q3
$1.18M Sell
3,938
-2,305
-37% -$692K ﹤0.01% 571
2024
Q2
$2.06M Buy
6,243
+3,311
+113% +$1.09M ﹤0.01% 437
2024
Q1
$1.16M Buy
2,932
+798
+37% +$316K ﹤0.01% 498
2023
Q4
$751K Buy
2,134
+445
+26% +$157K ﹤0.01% 681
2023
Q3
$634K Sell
1,689
-1,525
-47% -$572K ﹤0.01% 557
2023
Q2
$1.23M Sell
3,214
-1,315
-29% -$503K ﹤0.01% 384
2023
Q1
$1.57M Buy
4,529
+2,868
+173% +$994K 0.01% 436
2022
Q4
$391K Sell
1,661
-1,950
-54% -$459K ﹤0.01% 622
2022
Q3
$891K Buy
3,611
+104
+3% +$25.7K ﹤0.01% 607
2022
Q2
$1.08M Buy
3,507
+1,021
+41% +$313K ﹤0.01% 610
2022
Q1
$1.03M Sell
2,486
-1,621
-39% -$674K ﹤0.01% 720
2021
Q4
$1.93M Sell
4,107
-1,164
-22% -$546K ﹤0.01% 634
2021
Q3
$2.21M Buy
5,271
+241
+5% +$101K 0.01% 586
2021
Q2
$1.81M Buy
5,030
+481
+11% +$173K ﹤0.01% 596
2021
Q1
$1.28M Buy
4,549
+1,416
+45% +$399K ﹤0.01% 685
2020
Q4
$887K Buy
3,133
+1,301
+71% +$368K ﹤0.01% 709
2020
Q3
$504K Sell
1,832
-2,490
-58% -$685K ﹤0.01% 677
2020
Q2
$981K Buy
+4,322
New +$981K ﹤0.01% 476
2019
Q3
Sell
-5,000
Closed -$624K 943
2019
Q2
$624K Buy
5,000
+1,500
+43% +$187K ﹤0.01% 561
2019
Q1
$391K Buy
+3,500
New +$391K ﹤0.01% 627
2018
Q1
Sell
-4,124
Closed -$407K 1151
2017
Q4
$407K Sell
4,124
-981
-19% -$96.8K ﹤0.01% 879
2017
Q3
$491K Buy
5,105
+2,982
+140% +$287K ﹤0.01% 807
2017
Q2
$201K Buy
+2,123
New +$201K ﹤0.01% 993
2015
Q2
Sell
-4,660
Closed -$273K 1629
2015
Q1
$273K Sell
4,660
-1,120
-19% -$65.6K ﹤0.01% 1025
2014
Q4
$303K Buy
+5,780
New +$303K ﹤0.01% 1155
2014
Q3
Sell
-7,649
Closed -$322K 2112
2014
Q2
$322K Sell
7,649
-18,612
-71% -$784K ﹤0.01% 1338
2014
Q1
$1.16M Buy
+26,261
New +$1.16M ﹤0.01% 860